About 4 Trademarks found for “INREBIC”

Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoimmune disease, blood disease, cancer, arthritis in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations, namely, cytokine inhibitory drugs for use in the treatment of autoimmune diseases; pharmaceutical preparations, for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes, hematological tumors and blood tumors.

Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Pharmaceutical preparations for use in the treatment of myeloproliferative diseases, myelofibrosis, autoinflammatory disease, autoimmune disease, blood disease, cancer in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system.

Pharmaceutical and biological preparations for human use.